AHG: financial statements from SEC — TradeAlmanac

AHG

Akso Health Group: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue	15m	2m	13m	6m
Cost of revenue	15m	2m	12m	5m
Gross profit	−281,526	122,132	1m	605,134
Selling, general and administrative	4m	9m	16m	3m
Operating expenses	166m	9m	16m	4m
Operating income	−166m	−9m	−14m	−3m
Interest expense	—	—	—	804,138
Pre-tax income	−166m	−9m	−13m	−4m
Income tax	−31m	24,988	17,549	92,816
Net income	−135m	−9m	−1m	−17m
Earnings per share	−0.16	−0.07	−0.02	−0.28
Earnings per share, diluted	−0.16	−0.07	−0.02	−0.28
Weighted average shares	855m	142m	69m	60m
Weighted average shares, diluted	855m	142m	69m	60m

Balance sheet

Metric	Aug 18, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Apr 30, 2021	Mar 31, 2021
Cash and equivalents	—	176m	85m	8m	22m	—	15m
Receivables	—	954,200	—	8m

Cash flow

Metric	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating cash flow	1m	1m	−3m	−9m
Depreciation and amortisation	2m	—	—	—
Share-based compensation	—	—

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)